Abstract
In spite of advances in colorectal cancer treatments, approximately 1.4 million new global cases are estimated for 2015. In this sense, Brazilian plant diversity offers a multiplicity of essential oils as prospective novel anticancer compounds. This study aimed to evaluate the antiproliferative effect of the essential oils from four Lippia species in CT26.WT colon tumor cells, as a measurement of cell cycle phase distribution and microRNA expression. CT26.WT showed cell cycle arrest at G2/M phase after treatment with 100 μg/ml of Lippia alba (Mill.) N.E.Br. ex Britton & P. Wilson, Lippia sidoides Cham., and Lippia lacunosa Mart. & Schauer, Verbenaceae, essential oils and, at the same concentration, Lippia rotundifolia Cham. essential oil caused an augment of G0/G1 phase. The miRNA expression profiling shows change of expression in key oncogenic miRNAs genes after treatment. Our findings suggest growth inhibition mechanisms for all four essential oils on CT26.WT cells involving direct or indirect interference on cell cycle arrest and/or oncogenic miRNAs expression.
Article PDF
Similar content being viewed by others
References
Abdallah, H.M., Ezzat, S.M., 2011. Effect of the method of preparation on the composition and cytotoxic activity of the essential oil of Pituranthos tortuosus. Z. Naturforsch. C 66, 143–148.
Adams, R.P., 1995. Identification of Essential Oil Components by Gas Chromatography/Mass Spectrometry, 2nd ed. Allured Publishing Corporation, Carol Stream, Illinois, pp. 469.
Arndt, G.M., Dossey, L., Cullen, L.M., Lai, A., Druker, R., Eisbacher, M., Zhang, C., Tran, N., Fan, H., Retzlaff, K., Bittner, A., Raponi, M., 2009. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 9, 374.
Bandres, E., Cubedo, E., Agirre, X., Malumbres, R., Zarate, R., Ramirez, N., Abajo, A., Navarro, A., Moreno, I., Monzo, M., Garcia-Foncillas, J., 2006. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer 5, 29.
Braun, C.J., Zhang, X., Savelyeva, I., Wolff, S., Moll, U.M., Schepeler, T., Orntoft, T.F., Andersen, C.L., Dobbelstein, M., 2008. p53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 68, 10094–10104.
Burke, Y.D., Stark, M.J., Roach, S.L., Sen, S.E., Crowell, P.L., 1997. Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids 32, 151–156.
Carnesecchi, S., Langley, K., Exinger, F., Gosse, F., Raul, F., 2002. Geraniol, a component of plant essential oils, sensitizes human colonic cancer cells to 5-Fluorouracil treatment. J. Pharmacol. Exp. Ther. 301, 625–630.
Carnesecchi, S., Schneider, Y., Ceraline, J., Duranton, B., Gosse, F., Seiler, N., Raul, F., 2001. Geraniol, a component of plant essential oils, inhibits growth and polyamine biosynthesis in human colon cancer cells. J. Pharmacol. Exp. Ther. 298, 197–200.
Chaouki, W., Leger, D.Y., Liagre, B., Beneytout, J.L., Hmamouchi, M., 2009. Citral inhibits cell proliferation and induces apoptosis and cell cycle arrest in MCF-7 cells. Fundam. Clin. Pharmacol. 23, 549–556.
Chen, X., Guo, X., Zhang, H., Xiang, Y., Chen, J., Yin, Y., Cai, X., Wang, K., Wang, G., Ba, Y., Zhu, L., Wang, J., Yang, R., Zhang, Y., Ren, Z., Zen, K., Zhang, J., Zhang, C.Y., 2009. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28, 1385–1392.
Cloonan, N., Brown, M.K., Steptoe, A.L., Wani, S., Chan, W.L., Forrest, A.R., Kolle, G., Gabrielli, B., Grimmond, S.M., 2008. The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol. 9, R127.
Crowell, P.L., 1999. Prevention and therapy of cancer by dietary monoterpenes. J. Nutr. 129, 775S–778S.
Crowell, P.L., Gould, M.N., 1994. Chemoprevention and therapy of cancer by dlimonene. Crit. Rev. Oncog. 5, 1–22.
Deb, D.D., Parimala, G., Saravana Devi, S., Chakraborty, T., 2011. Effect of thymol on peripheral blood mononuclear cell PBMC and acute promyelotic cancer cell line HL-60. Chem. Biol. Interact. 193, 97–106.
Duncan, R.E., Lau, D., El-Sohemy, A., Archer, M.C., 2004. Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity. Biochem. Pharmacol. 68, 1739–1747.
Earle, J.S., Luthra, R., Romans, A., Abraham, R., Ensor, J., Yao, H., Hamilton, S.R., 2010. Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. J. Mol. Diagn. 12, 433–440.
Elegbede, J.A., Elson, C.E., Tanner, M.A., Qureshi, A., Gould, M.N., 1986. Regression of rat primary mammary tumors following dietary d-limonene. J. Natl. Cancer Inst. 76, 323–325.
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., Bray, F., 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359–E386.
Gomide, M.S., Lemos, F.O., Lopes, M.T.P., Alves, T.M.A., Viccini, L.F., Coelho, C.M., 2013. The effect of the essential oils from five different Lippia species on the viability of tumor cell lines. Rev. Bras. Farmacogn. 23, 895–902.
He, L., Mo, H., Hadisusilo, S., Qureshi, A.A., Elson, C.E., 1997. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J. Nutr. 127, 668–674.
Huang, Z., Huang, D., Ni, S., Peng, Z., Sheng, W., Du, X., 2010. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 127, 118–126.
Jaafari, A.T.M., Mouse, H.A., M’bark, L.A., Aboufatima, R., Chait, A., Lepoivre, M., Zyad, A., 2012. Comparative study of the antitumor effect of natural monoterpenes: relationship to cell cycle analysis. Rev. Bras. Farmacogn. 22, 534–540.
Kanaan, Z., Rai, S.N., Eichenberger, M.R., Barnes, C., Dworkin, A.M., Weller, C., Cohen, E., Roberts, H., Keskey, B., Petras, R.E., Crawford, N.P., Galandiuk, S., 2012. Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer. Hum. Mutat. 33, 551–560.
Kanthan, R., Senger, J.L., Kanthan, S.C., 2012. Molecular events in primary and metastatic colorectal carcinoma: a review. Patholog. Res. Int. 2012, 597497.
Kawamori, T., Tanaka, T., Hirose, Y., Ohnishi, M., Mori, H., 1996. Inhibitory effects of d-limonene on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Carcinogenesis 17, 369–372.
Kinghorn, A.F.N., Soejarto, D., Cordell, G., Swanson, S., Pezzuto, J., Wani, M., Wall, M., Oberlies, N., Kroll, D., et al., 2003. Novel strategies for the discovery of plantderived anticancer agents. Pharm. Biol. 41, 53–67.
Kulda, V., Pesta, M., Topolcan, O., Liska, V., Treska, V., Sutnar, A., Rupert, K., Ludvikova, M., Babuska, V., Holubec Jr., L., Cerny, R., 2010. Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet. Cytogenet. 200, 154–160.
Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 25, 402–408.
Mills, J.J., Chari, R.S., Boyer, I.J., Gould, M.N., Jirtle, R.L., 1995. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res. 55, 979–983.
2013. miRBase: the microRNA database [Internet]. Griffiths-Jones Lab, Faculty of Life Sciences, University of Manchester, Manchester, UK, Available from: http://www.mirbase.org/index.shtml (modified 2014 June; cited 2013 March).
Monteiro, M.V., de Melo Leite, A.K., Bertini, L.M., de Morais, S.M., Nunes-Pinheiro, D.C., 2007. Topical anti-inflammatory, gastroprotective and antioxidant effects of the essential oil of Lippia sidoides Cham. leaves. J. Ethnopharmacol. 111, 378–382.
Monzo, M., Navarro, A., Bandres, E., Artells, R., Moreno, I., Gel, B., Ibeas, R., Moreno, J., Martinez, F., Diaz, T., Martinez, A., Balague, O., Garcia-Foncillas, J., 2008. Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res. 18, 823–833.
Ng, E.K., Chong, W.W., Jin, H., Lam, E.K., Shin, V.Y., Yu, J., Poon, T.C., Ng, S.S., Sung, J.J., 2009a. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58, 1375–1381.
Ng, E.K., Tsang, W.P., Ng, S.S., Jin, H.C., Yu, J., Li, J.J., Rocken, C., Ebert, M.P., Kwok, T.T., Sung, J.J., 2009b. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br. J. Cancer 101, 699–706.
Ong, T.P., Heidor, R., de Conti, A., Dagli, M.L., Moreno, F.S., 2006. Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase. Carcinogenesis 27, 1194–1203.
Paduch, R., Kandefer-Szerszen, M., Trytek, M., Fiedurek, J., 2007. Terpenes: substances useful in human healthcare. Arch. Immunol. Ther. Exp. (Warsz) 55, 315–327.
Pascual, M.E., Slowing, K., Carretero, E., Sanchez Mata, D., Villar, A., 2001. Lippia: traditional uses, chemistry and pharmacology: a review. J. Ethnopharmacol. 76, 201–214.
Pfaffl, M.W., Horgan, G.W., Dempfle, L., 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36.
Ramos, A., Visozo, A., Piloto, J., Garcia, A., Rodriguez, C.A., Rivero, R., 2003. Screening of antimutagenicity via antioxidant activity in Cuban medicinal plants. J. Ethnopharmacol. 87, 241–246.
Sarver, A.L., French, A.J., Borralho, P.M., Thayanithy, V., Oberg, A.L., Silverstein, K.A., Morlan, B.W., Riska, S.M., Boardman, L.A., Cunningham, J.M., Subramanian, S., Wang, L., Smyrk, T.C., Rodrigues, C.M., Thibodeau, S.N., Steer, C.J., 2009. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 9, 401.
Schepeler, T., Reinert, J.T., Ostenfeld, M.S., Christensen, L.L., Silahtaroglu, A.N., Dyrskjot, L., Wiuf, C., Sorensen, F.J., Kruhoffer, M., Laurberg, S., Kauppinen, S., Orntoft, T.F., Andersen, C.L., 2008. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res. 68, 6416–6424.
Shoff, S.M., Grummer, M., Yatvin, M.B., Elson, C.E., 1991. Concentration-dependent increase of murine P388 and B16 population doubling time by the acyclic monoterpene geraniol. Cancer Res. 51, 37–42.
Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., Lin, C., Leach, C., Cannady, R.S., Cho, H., Scoppa, S., Hachey, M., Kirch, R., Jemal, A., Ward, E., 2012. Cancer treatment and survivorship statistics, 2012. CA Cancer J. Clin. 62, 220–241.
Visone, R., Russo, L., Pallante, P., De Martino, I., Ferraro, A., Leone, V., Borbone, E., Petrocca, F., Alder, H., Croce, C.M., Fusco, A., 2007. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr. Relat. Cancer 14, 791–798.
Volinia, S., Calin, G.A., Liu, C.G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., Prueitt, R.L., Yanaihara, N., Lanza, G., Scarpa, A., Vecchione, A., Negrini, M., Harris, C.C., Croce, C.M., 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103, 2257–2261.
Wattenberg, L.W., Coccia, J.B., 1991. Inhibition of 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone carcinogenesis in mice by d-limonene and citrus fruit oils. Carcinogenesis 12, 115–117.
Wiseman, D.A., Werner, S.R., Crowell, P.L., 2007. Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1) in human pancreatic adenocarcinoma cells. J. Pharmacol. Exp. Ther. 320, 1163–1170.
Yu, S.G., Hildebrandt, L.A., Elson, C.E., 1995. Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice. J. Nutr. 125, 2763–2767.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Authors’ contributions
MSG (M.Sc. student) contributed in collecting plant sample, extracting and analyzing the essential oil, running the laboratory work, analysis of the data and drafted the paper. FOL and MTPL contributed to biological studies and data discussion. DRLR and MAM contributed to microRNA analysis and to data discussion. GPCJ contributed to critical reading of the manuscript. TMAA contributed in GC/MS analysis. CMC designed the study, supervised the laboratory work and contributed to critical reading of the manuscript. All the authors have read the final manuscript and approved the submission.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Gomide, M., Lemos, F., Reis, D. et al. Identification of dysregulated microRNA expression and their potential role in the antiproliferative effect of the essential oils from four different Lippia species against the CT26.WT colon tumor cell line. Rev. Bras. Farmacogn. 26, 627–633 (2016). https://doi.org/10.1016/j.bjp.2016.04.003
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.bjp.2016.04.003